Access to innovative cancer medicines in a middle-income country - the case of Mexico
Background Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin American countries, Mexico has an essential cancer medicines list that includes innova...
Saved in:
Main Authors: | Daniela Moye-Holz (Author), Rene Soria Saucedo (Author), Jitse P van Dijk (Author), Sijmen A Reijneveld (Author), Hans V Hogerzeil (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country
by: Daniela Moye-Holz, et al.
Published: (2017) -
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2020) -
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
by: Chaoyang Li, et al.
Published: (2024) -
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
by: Chaoyang Li, et al.
Published: (2024) -
Access to medicines for acute illness in middle income countries in Central America
by: Isabel Cristina Martins Emmerick, et al.
Published: (2013)